Physician Supervision of Patient Administration

The language of the decision would suggest that the physician would be required to observe the patient taking the first dose of Mifegymiso. This requirement has been interpreted as demeaning to women. Health Canada has indicated that this is not what they intended through this restriction but lack of clarity in the Summary Basis of Decision’s wording would seem to imply this expectation.